PD1抑制剂联合呋喹替尼及TAS-102后线治疗晚期结直肠癌的临床价值研究
苏小琴,陈希,范海华,季从飞,倪婷婷,于洋,陈佳
The clinical value of PD1 inhibitor combined with furoquantinib and TAS⁃102 posterior therapy for advanced colorectal cancer
Xiaoqin SU,Xi CHEN,Haihua FAN,Congfei JI,Tingting NI,Yang YU,Jia. CHEN
实用医学杂志
.
2023, (18): 2389
-2394
.
DOI: 10.3969/j.issn.1006-5725.2023.18.018
|
|
|
